Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 16.06
-0.03 (-0.19%)
Jun 18, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.22 billion as of June 17, 2026. Its market cap has decreased by -38.68% in one year.
Market Cap
7.22B
Enterprise Value
5.13B
Revenue
2.73B
Ranking
n/a
PE Ratio
13.98
Stock Price
16.06
Market Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.22B, a decrease of -22.74%. That is a compound annual growth rate of -2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 7.42B | -26.99% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.93B |
| Everest Medicines | 9.54B |
| CARsgen Therapeutics Holdings | 9.42B |
| HBM Holdings | 9.18B |
| Suzhou Ribo Life Science | 8.66B |
| CStone Pharmaceuticals | 7.72B |
| Lepu Biopharma | 7.06B |
| Alphamab Oncology | 6.79B |